Gene: MYPOP
Official Full Name: Myb related transcription factor, partner of profilinprovided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in negative regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO15938 | MYPOP Knockout cell line (HeLa) | Human | MYPOP | 1:3~1:6 | Negative | Online Inquiry |
KO15939 | MYPOP Knockout cell line (HCT 116) | Human | MYPOP | 1:2~1:4 | Negative | Online Inquiry |
KO15940 | MYPOP Knockout cell line (HEK293) | Human | MYPOP | 1:3~1:6 | Negative | Online Inquiry |
KO15941 | MYPOP Knockout cell line (A549) | Human | MYPOP | 1:3~1:4 | Negative | Online Inquiry |
MYPOP Gene Knockout Cell Lines are a revolutionary suite of genetically engineered cell lines designed to facilitate gene functional studies and elucidate biological pathways. Utilizing the CRISPR-Cas9 gene-editing technology, these cell lines have been meticulously developed to target specific genes, enabling researchers to create precise knockout models that are invaluable for investigating gene functions, disease mechanisms, and therapeutic targets.
The key function of MYPOP Gene Knockout Cell Lines lies in their ability to provide a controlled environment where specific genes are rendered non-functional. This mechanism allows for the assessment of phenotypic changes brought about by gene loss, making it indispensable in studies of gene redundancy and compensatory mechanisms. Moreover, the use of MYPOP cell lines significantly enhances the rigor of experimental reproducibility and provides robustness to experimental design, given the clean and targeted edits that minimize off-target effects.
Scientifically, MYPOP Gene Knockout Cell Lines find applications across various research domains, including cancer biology, regenerative medicine, and pharmacogenomics. Their ability to model specific genetic disorders provides researchers with a critical tool in the quest for novel therapeutic interventions and understanding complex diseases. In clinical settings, these cell lines can expedite the drug discovery process by facilitating high-throughput screening of compounds against specific genetic backgrounds.
Our MYPOP Gene Knockout Cell Lines stand out from alternative products due to our commitment to quality and customization. We offer a wide range of cell lines tailored to specific research needs, coupled with comprehensive support and extensive validation data. This bespoke service ensures that our clients receive products that are optimally designed to fit their experimental requirements.
For researchers and clinicians navigating the complexities of gene function and its implications in health and disease, MYPOP Gene Knockout Cell Lines are not just a product but a gateway to transformative discoveries. Backed by our extensive expertise in genetic engineering and cell biology, our offerings are developed with a focus on innovation and efficacy, ensuring that you have the tools necessary to advance your research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.